Chairman Li Qiling increases his holdings of Dongrui Pharmaceutical (02348.HK) by 52,000 shares at a price of 1.22 Hong Kong dollars per share.

According to the China Fortune Finance app, the latest data from the Hong Kong Stock Exchange shows that on November 3, Chairman Li Qiling increased his holdings of Dongrui Pharmaceuticals (02348.HK) by 52,000 shares, with a price of 1.22 Hong Kong dollars per share, for a total amount of approximately 63,400 Hong Kong dollars. After the increase, the latest number of shares held is approximately 711 million shares, with the latest shareholding ratio at 47.26%.